322 related articles for article (PubMed ID: 18452429)
1. C6-peptide serology as diagnostic tool in neuroborreliosis.
Tjernberg I; Schön T; Ernerudh J; Wistedt AC; Forsberg P; Eliasson I
APMIS; 2008 May; 116(5):393-9. PubMed ID: 18452429
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
3. High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients.
van Burgel ND; Brandenburg A; Gerritsen HJ; Kroes AC; van Dam AP
Clin Microbiol Infect; 2011 Oct; 17(10):1495-500. PubMed ID: 21375653
[TBL] [Abstract][Full Text] [Related]
4. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients.
Blanc F; Jaulhac B; Fleury M; de Seze J; de Martino SJ; Remy V; Blaison G; Hansmann Y; Christmann D; Tranchant C
Neurology; 2007 Sep; 69(10):953-8. PubMed ID: 17785663
[TBL] [Abstract][Full Text] [Related]
5. [Clinical forms of neuroborreliosis among hospitalized patients in the years 2000-2005].
Czupryna P; Kuśmierczyk J; Zajkowska JM; Ciemerych M; Kondrusik M; Ciemerych A; Pancewicz SA
Pol Merkur Lekarski; 2007 Aug; 23(134):103-6. PubMed ID: 18044338
[TBL] [Abstract][Full Text] [Related]
6. [Clinical spectrum and incidence of neuro-borreliosis in the Netherlands].
Kuiper H
Ned Tijdschr Geneeskd; 2004 Apr; 148(14):670-3. PubMed ID: 15106319
[TBL] [Abstract][Full Text] [Related]
7. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid.
Skogman BH; Croner S; Forsberg P; Ernerudh J; Lahdenne P; Sillanpää H; Seppälä I
Pediatr Infect Dis J; 2008 Jul; 27(7):605-12. PubMed ID: 18536620
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic difficulties in neuroborreliosis in children].
Talarek E; Duszczyk E; Zarnowska H
Przegl Epidemiol; 2007; 61(1):73-8. PubMed ID: 17702442
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide.
Panelius J; Lahdenne P; Saxén H; Carlsson SA; Heikkilä T; Peltomaa M; Lauhio A; Seppälä I
J Neurol; 2003 Nov; 250(11):1318-27. PubMed ID: 14648148
[TBL] [Abstract][Full Text] [Related]
11. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid.
Vermeersch P; Resseler S; Nackers E; Lagrou K
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):347-9. PubMed ID: 19376674
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
13. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid.
Gooskens J; Templeton KE; Claas EC; van Dam AP
Clin Microbiol Infect; 2006 Sep; 12(9):894-900. PubMed ID: 16882295
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to recombinant decorin-binding proteins A and B in the cerebrospinal fluid of patients with Lyme neuroborreliosis.
Panelius J; Sillanpää H; Seppälä I; Sarvas H; Lahdenne P
Scand J Infect Dis; 2007; 39(9):775-80. PubMed ID: 17701715
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to borrelial VlsE IR6 peptide variants.
Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
[TBL] [Abstract][Full Text] [Related]
17. T-cell epitope mapping of the Borrelia garinii outer surface protein A in lyme neuroborreliosis.
Widhe M; Ekerfelt C; Jarefors S; Skogman BH; Peterson EM; Bergström S; Forsberg P; Ernerudh J
Scand J Immunol; 2009 Aug; 70(2):141-8. PubMed ID: 19630920
[TBL] [Abstract][Full Text] [Related]
18. Borrelia antibodies in children evaluated for Lyme neuroborreliosis.
Bennet R; Lindgren V; Zweygberg Wirgart B
Infection; 2008 Oct; 36(5):463-6. PubMed ID: 18791841
[TBL] [Abstract][Full Text] [Related]
19. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms.
Tveitnes D; Øymar K; Natås O
Scand J Infect Dis; 2009; 41(5):355-62. PubMed ID: 19253089
[TBL] [Abstract][Full Text] [Related]
20. Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients.
Ljøstad U; Mygland A
Neurology; 2008 Jul; 71(2):151; author reply 151-2. PubMed ID: 18606973
[No Abstract] [Full Text] [Related]
[Next] [New Search]
